Enanta Pharmaceuticals DSO Ratio 2011-2026 | ENTA

Annual DSO Ratio Enanta Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
37.8	41.2	66.7	93	88.5	111	91.3	119	37.7	53.1	35.7	34.4	18.1	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
119	18.1	63.7

Quarterly DSO Ratio Enanta Pharmaceuticals

2025-Q4	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
41.2	37.7	44.4	38.6	-	40.5	42.6	42.5	-	88.6	104	83	27.6	89.5	113	84.5	28.1	95.4	125	79.4	90.7	115	109	90.2	91.2	106	105	89.5	91.2	107	93.5	40.4	12.8	129	107	102	91.2	83.8	135	31.2	96.8	120	86.6	46.1	59.7	3.74	1.18	55.5	54.7	44.7	41.3	1.72	51.5	18.8	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
135	1.18	71.3

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Takeda Pharmaceutical Company Limited TAK	79.3	$ 18.06	-	$ 28.2 B	Japan
Amphastar Pharmaceuticals AMPH	70.9	$ 19.44	-0.46 %	$ 909 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Tarsus Pharmaceuticals TARS	53.3	$ 67.0	-0.3 %	$ 2.8 B	USA
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Theravance Biopharma TBPH	251	$ 14.9	-1.91 %	$ 750 M	Cayman-islands
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Bio-Techne Corporation TECH	67.1	$ 51.31	-2.65 %	$ 8.08 B	USA
Tenax Therapeutics TENX	566	$ 14.64	-2.2 %	$ 574 M	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Teva Pharmaceutical Industries Limited TEVA	823	$ 28.76	-3.43 %	$ 32.9 B	Israel
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Equillium EQ	16.6	$ 2.03	-1.46 %	$ 116 M	USA
Eton Pharmaceuticals ETON	39.1	$ 23.81	1.51 %	$ 641 M	USA
CRISPR Therapeutics AG CRSP	1.1 K	$ 46.38	-2.45 %	$ 4.17 B	Schweiz